Cardiovascular effects of the new nitric oxide donor, pirsidomine. Hemodynamic profile and tolerance studies in anesthetized and conscious dogs
- 10 September 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 220 (1) , 71-78
- https://doi.org/10.1016/0014-2999(92)90013-t
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- CAS 936, a Novel Sydnonimine with Direct Vasodilating and Nitric Oxide-Donating PropertiesJournal of Cardiovascular Pharmacology, 1991
- Role of cytochrome P-450 in the biotransformation and mechanism of action of organic nitratesEuropean Journal of Pharmacology, 1990
- On the Mechanism of NO Release from SydnoniminesJournal of Cardiovascular Pharmacology, 1989
- Oxygen and Oxidation Promote the Release of Nitric Oxide from SydnoniminesJournal of Cardiovascular Pharmacology, 1989
- Persistence of the Response to SIN1 on Isolated Coronary Arteries Rendered Tolerant to Nitroglycerin In Vitro or In VivoJournal of Cardiovascular Pharmacology, 1988
- Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclaseEuropean Journal of Pharmacology, 1987
- Technical notes on chronic fluid-filled catheters and renal artery constrictors for testing hemodynamic drug effects in conscious hypertensive dogsJournal of Pharmacological Methods, 1986
- Dissociation of cysteine and glutathione levels from nitroglycerin-induced relaxationEuropean Journal of Pharmacology, 1985
- The effect of repeated intravenous and oral doses of molsidomine (N-carboxy-3-morpholino-sydnonimine-ethylester) on plasma renin activity and plasma catecholamine levels in conscious dogsBasic Research in Cardiology, 1983
- Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failureThe American Journal of Medicine, 1981